5xpr
From Proteopedia
(Difference between revisions)
m (Protected "5xpr" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | == | + | ==Human endothelin receptor type-B in complex with antagonist bosentan== |
<StructureSection load='5xpr' size='340' side='right' caption='[[5xpr]], [[Resolution|resolution]] 3.60Å' scene=''> | <StructureSection load='5xpr' size='340' side='right' caption='[[5xpr]], [[Resolution|resolution]] 3.60Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5xpr]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5XPR OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5XPR FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5xpr]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5XPR OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5XPR FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=K86:4-tert-butyl-N-[6-(2-hydroxyethyloxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide'>K86</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=K86:4-tert-butyl-N-[6-(2-hydroxyethyloxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide'>K86</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">EDNRB, ETRB ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5xpr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5xpr OCA], [http://pdbe.org/5xpr PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5xpr RCSB], [http://www.ebi.ac.uk/pdbsum/5xpr PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5xpr ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5xpr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5xpr OCA], [http://pdbe.org/5xpr PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5xpr RCSB], [http://www.ebi.ac.uk/pdbsum/5xpr PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5xpr ProSAT]</span></td></tr> | ||
| Line 25: | Line 26: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
[[Category: Lysozyme]] | [[Category: Lysozyme]] | ||
[[Category: Doi, T]] | [[Category: Doi, T]] | ||
Revision as of 10:17, 15 November 2017
Human endothelin receptor type-B in complex with antagonist bosentan
| |||||||||||
Categories: Human | Lysozyme | Doi, T | Fujiyoshi, Y | Hirata, K | Nishizawa, T | Nureki, O | Okuta, A | Shihoya, W | Tani, K | Yamashita, K | Alpha helical | Signaling protein
